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~ Effect of  Warfarin Anticoaguiction on Survival In 
Patients With Left Ventricular Systolic Dysfunction 
Ayman S. Al-Khadra, Deeb N. Salem, William M. Rand, James E. Udelson, 
John J. Smith, Marvin A. Konstam. NEMC ~ Tufts University, Boston, MA 
Relative dsk (RR) and confldertca interval (Cl) for warfadn users vs. non-users 
Endpoint RR 95% CI P 
All cause ntorla;~ 0.76 0.65-0.91 0.000S 
Cardiacdealhs 0.72 0.61-0.85 0.000~ 
Death due to heart failure (HI=) 0.77 0.61-0.98 0.03 
Cardiac death not due to HF 0.66 0.47-0.91 0.01 
Fatal MI 0.55 0.34-0.90 0.02 
The impact of warfarin theraw on survival in patients with chronic heart 
failure or LV systolic dysfunction is unknown. We analyzed survival in tale- 
lion to warfadn therapy, in 6787 patients with LV EF _< 0,35 enrolled in the 
SOLVD trial. Mean follow-up was approximately 40 months. Patients receiv- 
ing wadafin (13.3%o, n = 908) had lower mean EF, lower rate of antiplatelet 
agents use, and worse NYHA class, and higher prevalence of atdal fibrilla- 
tion, antiarrhythmic agents and digoxin use, carebrovaseular disease, and 
non-ishemic LV dysfunction (all P < 0.05). There was no difference in study 
drug (enal~rit) randomization. After adjusting for these differences and for 
age, sex and trial assignment (prevention vs. treatment trial), using Cox pro- 
portional hazard model, anticoagulation emerged as a significant predictor 
of favorable outcome and was associated with 24% relative dsk reduction in 
all-cause mortality (95% CI 11% to 35%, P = 0.0006). Acticoagutation was 
associated with reduction in cardiac mortality, including mortality due to fatal 
MI, sudden death and heart failure. 
The reduction in all cause mortality was present in all subgroups based on 
trial assignment, randomization to enalapril, underlying etiology and presence 
of atrial fibrillation. There was no interaction between the effect of warfadn 
and age or El = . 
Conclusion: Warfadn anticoagulation i  patients with LV systolic dysfunc- 
tion is associated with improved survival regardless of etiology, symptom 
class, or EF. 
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~ '~ '~A 25-Year Experience in Patients (Pts) W'dh 
Coronary Artery Disease (CAD) and Chronic Ho_,rt 
Failure (CHF): Outcomes With Medical Therapy and 
Bypass Surgery (CABG) 
Chdstopher M. O'Connor, Joseph A. Puma, Laura H, Gardner, Robed 
M. Califf, Robed H. Jones. Duke University Medical Center, Durham, NC 
Recent advances in the medical management of pts with CAD and CHF have 
led us to re-examine the role of revascutsfizction, To detsn~lne the effects of 
CABG in these pts, we prospectively collected ata on 33,581 consecutive 
lots undergoing cardiac cathetedzati0n between 1969 and 1994. Of those 
pts with ejection froctions < 40% and Class If-IV CHF, 1,088 were treated 
medically and 354 with CABG. 
Baseline characteflsttcs were similar in both ~roup~ except for more 3- 
vessel disease (67% vs, 50%) and prior myocardial infarctions (88% vs. 
76%) in the CABG group, and more moderate or severe mflral regurgitation 
(16% vs. 6%) in the medical group, Angina within 6 weeks of anglography was 
reported in 53% of medical pts and 71% of CABG pts. Long term outcome 
revealed: 
UcadJusted Kaplan-Meler Survival Estimates 
Medicine CABG p-Value 
1 year (%) 71 77 0.17 
5 years (%) 3~ 55 0.0001 
10 Years (%) 15 35 0.0001 
There was a comparable 5 year suwival advantage in the CABG cohort 
compared t(, the medical cohort in pts with angina (56% vs 26%) and without 
angina (SL~ ve 29%) respectively. Conclusion: Pts with clinical CHF and 
CAD have Improved survival with CABG which is not altered by the absence 
el anginal symptoms. 
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~ - ]  Late Recovery of Left Ventdcular Dysfunction After 
Mitral Repair: Predictive Value o f  Preoperative 
IF~(ercise Echocardiography 
Dominic Y. Leung, Bfiee P, Gdltln, William J. Stewart, Brian Haluska, 
Delos Cosgrove, James D. Thomas, Thomas H. Marwick. Cleveland Clinic 
Foundatfbn. Cleveland, Ohio 
Left ventdcular (LV) dysfunction earlyafter valve repair for mitrat regurgitation 
(MR) correlated better with preoperative (preep) exercise (Ex) than resting 
indices of LV function. However, whether early LV dysfunction is reversible 
and the role of preoperative cho in identifying late recovery are unclear. 
We Performed Ex echo in 67 pts (age 53 ± 13 yrs, 50 men, 49 tn functional 
class (FC) I and 18 FC it) without coronary disease undergoing repair for 
isolated MR. Its underwent resting echo before discharge and > 1 year 
later. Results: Resting ejection fraction (El =) decreased from 64:1:9%0 precp 
to 64 :t: 10% early after uncomplicated mitral repair (p < 0.001). Early post 
repair, 17 lots (25%) developed LV dysfunction with EF < 50%. Late follow 
up echo was obtained in 28 pts (mean 1.7 yrs pest repair): 19 of the 28 pts 
with eady pest repair EF > 50°/, remained in FC I and had resting EF > 
50%. For the remaining 9 pts with eady post repair EF < 50%, late follow up 
showed recovery of LV function (EF >_ 50%) in 5 and no recovery in 4 (EF 
< 50%). Late EF was correlated with preop ESVEx (p = 0.002) and Ex EF (p 
= 0.001). Its with late recovery, compared to lots without, were younger (44 
4- 11 ve 65 ~. 7 years, p = 0.01), had a higher preop Ex EF (63 4- 10% vs 
46 ± 8%, p = 0.03) and a lower resting end systolic walt stress (p = 0.09). 
There was no difference in preop resting EF, dp/dt, ESDnest, ESV~ and eady 
post repair EF between the 2 groups. Conclusions: 1) LV dysfunction eady 
post repair is often reversible, 2) Preop Ex index measured as Ex EF are 
helpful in predicting late recovery, 3) Ex echo, by identifying tots with latent 
LV dysfunction, may allow eady surgery for these pta and may improve tong 
term outcome, 
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~Laek  of Improvement In Exercise Duration or 
Functional Stetus After Valve Replacement for 
Aort ic Stenosla 
Bred Munt, Malcolm Legget, Michelle Fujioka, Rebecca Schwaegisr, 
Nancy Healy, Cathedne Otto. University of Washington, Seattle, WA 
Although the survival advantage of valve replacement (AVR) for symptomatic 
aodic stanosis (AS) has been welt-documented, there is little data on changes 
in exercise tolerance or functional status post-AVR. Late improvement post- 
AVR might be expected if diastolic function abnormalities persist eady post- 
AVR. Thus, we compared pre- and post-AVR echocardiographlc, exe~se, 
a~';,l functional status data in 29 adults (mean age 66 -;- 15 yrs) enrolled in a 
prospective study of AS with annual follow-up. A pre-AVR echecardlogram 
(n = 29) and exercise test (n = 19) was performed 4 ~ 3 months pre-AVR 
(before the onset of symptoms) with the eady post-AVR study perfon/F3d 12 
months later in all 29 pts. In 19 pts a late post-AVR study was performed 2 
years later. 
As expected, maximum jet velocity (4.6:1:0.6 to 2.8.4- 0.7 m/s, p < 0.001) 
and mean gradient decreased (53 ± 15 to 19 • 10 mmHg, p < 0.001), and 
valve area increased (0.9 * 0.4 to 1.8 ± 0.8 cm ~, p < 0.001). In addition, 
ejection fraction increased ftom 61 ± 17 to 67 ± 10% (p = 0.05) and LV-maas 
decreased horn 164 + 49 to 136 ± 33 gm (p ,, 0.003) with persistance of 
these changes on the late post-AVR study. The mitrel E/A raUo (1,2 "~ 0.6 
to 1,3 4- 0.7) and deceleration elope (3.0 • 1.7 to 3.7 ± 2,3 m/s 2) were 
unchanged (p - NS) at both the early and lath post-AVR studies. Standard 
Bruce protocol exercise duration was 4.3:1:2.6 rain pm-AVR vs 4A ± 1.9 
rain post-AVR (p = NS). The fuqcttonal status score based on a standard 
questionnaire of daily activities [ranging from 0 (w '~,e) to 100% (best)] also 
was unchanged (90 ~: 12 to g0 ~ 11%, p = NS). 
We conclude that when AVR is performed promptly at symptom onset, 
despite improved LV systolic function and decreased LV mass, there ison 
change in diastolic function, exe,-x:tse totscance, or functiof~t status, 
